Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ: 001540)

Ahn-Gook Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15,166	28,991	18,219	13,650	12,768	22,746
Short-Term Investments	5,950	5,050	11,050	7,496	6,877	20,897
Trading Asset Securities	7,518	1,405	9,173	26,314	30,624	35,707
Cash & Short-Term Investments	28,635	35,446	38,442	47,460	50,269	79,350
Cash Growth	-23.47%	-7.79%	-19.00%	-5.59%	-36.65%	44.93%
Accounts Receivable	65,963	62,132	54,917	43,059	33,060	43,877
Other Receivables	214.33	461.03	519.21	817.96	1,250	1,593
Receivables	66,338	62,753	55,597	44,159	37,737	45,810
Inventory	41,177	35,718	26,594	23,891	22,669	23,505
Prepaid Expenses	227.83	130.74	75.04	90.25	211.36	459.69
Other Current Assets	1,689	1,368	1,302	683.49	545.92	3,015
Total Current Assets	138,067	135,416	122,010	116,285	111,432	152,139
Property, Plant & Equipment	124,148	73,036	70,771	70,911	70,554	48,036
Long-Term Investments	26,615	22,927	23,037	26,872	12,206	9,071
Other Intangible Assets	4,144	4,287	4,087	3,874	3,378	3,579
Long-Term Deferred Tax Assets	1,294	1,722	2,816	843.94	2,602	1,673
Other Long-Term Assets	9,499	1,208	1,193	1,171	1,529	3,459
Total Assets	303,767	238,598	223,912	219,956	201,702	217,957
Accounts Payable	14,466	15,208	12,643	10,141	9,048	10,555
Accrued Expenses	10,744	10,619	8,974	6,141	1,257	654.26
Short-Term Debt	27,300	17,300	19,450	19,600	19,900	27,857
Current Portion of Long-Term Debt	-	-	8.25	60.93	144.72	111.72
Current Portion of Leases	177.75	259.14	336.51	296.49	357.66	449.55
Current Income Taxes Payable	4,394	238.13	1,369	383.15	-	-
Current Unearned Revenue	-	-	0.78	18.55	3.23	32.04
Other Current Liabilities	21,535	34,619	18,717	15,572	13,967	16,623
Total Current Liabilities	78,617	78,242	61,498	52,212	44,678	56,282
Long-Term Debt	50,000	-	-	8.25	69.18	246.9
Long-Term Leases	215.1	120.27	210.13	225.69	332.83	300.94
Other Long-Term Liabilities	660.95	520.06	402.69	316.44	209.46	185.06
Total Liabilities	137,653	86,932	69,241	66,675	57,558	69,599
Common Stock	6,521	6,521	6,521	6,521	6,521	6,521
Additional Paid-In Capital	15,531	15,531	15,531	15,531	15,547	15,531
Retained Earnings	146,489	131,553	133,487	127,754	126,215	130,170
Treasury Stock	-4,941	-4,941	-4,941	-4,387	-3,967	-3,952
Comprensive Income & Other	2,999	3,422	4,199	8,001	-217.19	-24.48
Total Common Equity	166,600	152,086	154,798	153,421	144,098	148,247
Minority Interest	-486.03	-420.65	-126.44	-140.14	45.11	111.81
Shareholders' Equity	166,114	151,666	154,671	153,281	144,144	148,358
Total Liabilities & Equity	303,767	238,598	223,912	219,956	201,702	217,957
Total Debt	77,693	17,679	20,005	20,191	20,804	28,966
Net Cash (Debt)	-49,058	17,767	18,437	27,269	29,465	50,384
Net Cash Growth	-	-3.63%	-32.39%	-7.45%	-41.52%	45.33%
Net Cash Per Share	-4316.47	1563.26	1620.25	2380.83	2329.62	4396.85
Filing Date Shares Outstanding	11.37	11.37	11.37	11.41	11.46	11.46
Total Common Shares Outstanding	11.37	11.37	11.31	11.41	11.46	11.46
Working Capital	59,450	57,174	60,511	64,072	66,754	95,857
Book Value Per Share	14658.58	13381.56	13683.36	13441.11	12574.97	12936.96
Tangible Book Value	162,456	147,799	150,711	149,547	140,720	144,667
Tangible Book Value Per Share	14293.95	13004.33	13322.13	13101.72	12280.16	12624.62
Land	38,953	19,501	19,501	19,501	19,501	18,842
Buildings	80,448	34,393	19,510	34,222	33,855	33,363
Machinery	33,452	34,066	29,974	33,184	31,149	30,393
Construction In Progress	6,743	24,210	22,712	21,973	21,432	141.19

Source: S&P Capital IQ. Standard template. Financial Sources.